Matt Rider
Analyst · Citi. Please go ahead
Thank you, Lard, and good morning, everyone. Let me start with an overview of our capital position on Slide 10. As a reminder, operating capital generation and free cash flow for this quarter and for the comparative period last year exclude the contributions from Aegon the Netherlands following the transaction with a.s.r. Operating capital generation before holding, funding and operating expenses amounted to €292 million for the first quarter of 2023. The increase compared with the prior year's first quarter reflects business growth and improvement in claims experience and lower expenses. Free cash flow of €47 million mainly reflects remittances from Aegon's asset management joint venture in China. As a result of the previously announced share buyback, cash capital at the holding decreased to €1.4 billion at the end of the first quarter as planned. Our gross financial leverage amounted to €5.6 billion or €5.4 billion based on a euro-U.S. dollar exchange rate of $1.20, which is the rate at which we set our deleveraging target in 2020. This means that we remain within our target range. Against the continued volatile backdrop, the Group Solvency II ratio increased by two percentage points over the first quarter to 210%, driven by capital generation and an increase of diversification benefits. For our three main units, we maintained strong capital ratios with each of them remaining above their respective operating levels. Let me talk to the movements of the capital ratios on Slide 11, U.S. RBC ratio increased by 11 percentage points over the quarter to 436%. This is mainly driven by strong operating capital generation for the quarter, partly offset by dividends to the intermediate holding company. There was a positive impact from market movements and one-time items. These were primarily driven by a tax benefit. As in the previous couple of quarters, the impact of credit impairments and rating migrations on the RBC ratio was negligible. The Solvency II ratio of the Dutch Life unit decreased to 191%, and mainly due to a refinement of the internal model. We adjusted the correlation parameters, which led to an increase in required capital. This is a stock and flow impact because the required capital will be released over time as the business runs off. Market movements also had a negative impact, mainly as a result of lower real estate revaluations and spread movements, the solvency ratio of Scottish Equitable, our main legal entity in the U.K., increased by two percentage points to 171%. Let me now turn to Slide 12 to give you more detail on Aegon's operating capital generation in the first quarter. Total operating capital generation before expenses for holding, funding and operating expenses, was €292 million this quarter. This is an increase of 5% compared with the first quarter of 2022. Earnings on in-force before holding expenses contributed €355 million to operating capital generation, an increase of 17% compared with the prior year's quarter. The increase was driven by Transamerica and reflects improved claims experience, reduced expenses and growth of our Strategic Assets. The increase in earnings on in-force was partly offset by higher new business strain compared with last year, mainly from profitable business growth in the U.S. Individual Life and Retirement plan businesses. This is in line with our ambition to allocate capital to those businesses where we can build leading positions and generate attractive returns. The release of required capital was higher than usual, mainly as a result of the repayment of a short-term loan. This reduced collateral requirements, which in turn led to a release of required capital. All in all, we remain on track to meet our guidance of at least €1 billion operating capital generation from the units in 2023. On Slide 13, you can see that cash capital at the holding decreased to €1.4 billion during the quarter, which is in the upper half of the operating range. In the first quarter of 2023, we spent a total of €152 million on share buybacks. €109 million of this was a consequence of the €200 million share buyback program that we announced at our fourth quarter earnings release. The remaining €43 million related to buybacks needed to meet our obligations resulting from share-based compensation plans. Free cash flow for the quarter was mainly driven by a dividend from our Chinese asset management joint venture, AIFMC. This was largely offset by capital injections into country units, mainly related to our business in India. Let me now turn the page for an update on our financial assets on Slide 14. Here, we summarize the continued value creation from our financial assets, where we increasingly benefit from the actions we have taken on these books over the last years. In the first quarter, we continued our track record of successfully hedging the targeted risks, embedded in our variable annuity guarantees, achieving 97% hedge effectiveness. In Long-Term Care, our primary management actions are rate increase programs. We have obtained regulatory approvals for additional rate increases worth USD42 million in the first quarter. The total value of approvals achieved since the start of the program now stands at $513 million, and we will continue to work with state regulators to get pending and future actuarially justified rate increases approved. The Dutch Life insurance business generated € 111 million of operating capital generation, more than covering the € 75 million in remittances that the business paid to the intermediate Dutch holding company. Let me conclude with some words on the strength of our balance sheet on Slide 15. The start of this year has been volatile as a result of issues in the banking sector in both Europe and the U.S., following continued interest rate hikes from central banks to curb inflation. We have navigated this market environment well, benefiting from the actions that we have taken to improve our risk profile and strengthen our balance sheet. We have significant financial flexibility with strong capital positions in the units and cash capital at the holding near the upper end of the operating range. Next to this, Aegon maintains a conservative and well diversified fixed income portfolio. Our U.S. corporate bond portfolio is defensively positioned with an overweight to higher-rated bonds relative to the benchmark and is diversified across industries. For the banking sector specifically, Transamerica has limited exposure to U.S. regional banks and within the sub-segment has focused on higher rated banks and instruments. In addition, we have a robust liquidity management framework. And as a consequence, we are overweight liquid assets compared to other U.S. life insurance companies. In the Netherlands as well as in the U.S., we are invested in mortgages. The Dutch mortgage book is focused on residential housing with a low loan-to-value ratio of 54% and is known for its very low delinquencies, even in unfavorable economic environments. Similarly, the commercial mortgage loan portfolio in the U.S. has a low loan-to-value ratio of 50%. More than half the book is invested in multifamily residential properties and the book has limited near-term maturities. Our direct real estate exposure in the U.S. and - in the Netherlands and in the U.S. totaled €6 billion. This is a defensively positioned portfolio with significant investments in residential properties, especially in the Netherlands. The overall direct real estate exposure to office properties across our portfolio is very limited at around €200 million or less than 20 basis points of our combined general account in the U.S. and in the Netherlands. As we look ahead, our financial flexibility and disciplined investment approach put us in a strong position to navigate the current macroeconomic environment and execute on our strategy. And with that final note, I now pass it back to you, Lard, for your concluding remarks.